Tech Company Financing Transactions
Ovuline Funding Round
Ovuline, based in Cambridge, raised $3.2 million from private investors.
Transaction Overview
Company Name
Announced On
5/26/2015
Transaction Type
Venture Equity
Amount
$3,219,992
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
10 Magaine St. 1005
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Ovuline helps couples conceive faster. Going way beyond fertility calendars and period trackers, Ovuline tells couples when they are fertile and exactly what to do each day to maximize their chances of getting pregnant. Ovuline can also be used to avoid pregnancy or track menstrual cycles.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paris Wallace
Chief Technical Officer
Alex Baron
VP - Engineering
Rory O'Connor
VP - Product Management
Gina Nebesar
Browse more venture capital transactions:
Prev: 5/26/2015: Mitoo venture capital transaction
Next: 5/26/2015: QR Pharma venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs